Alpha Cognition Inc. (NASDAQ:ACOG – Get Free Report) has earned a consensus rating of “Buy” from the four ratings firms that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $17.25.
Several equities research analysts have issued reports on ACOG shares. Maxim Group assumed coverage on Alpha Cognition in a research report on Friday, May 29th. They set a “buy” rating and a $12.00 target price on the stock. HC Wainwright lifted their price target on Alpha Cognition from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Monday. B. Riley Financial began coverage on Alpha Cognition in a research note on Thursday. They set a “buy” rating on the stock. Wall Street Zen upgraded Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday. Finally, Raymond James Financial assumed coverage on Alpha Cognition in a report on Friday, July 10th. They set an “outperform” rating and a $20.00 price objective on the stock.
Get Our Latest Stock Analysis on Alpha Cognition
Alpha Cognition News Summary
- Positive Sentiment: HC Wainwright maintained its Buy rating and $20 price target, well above recent trading levels. The firm also raised its Q1 2027 EPS estimate to a loss of $0.12 from $0.19 and lifted its FY2027 forecast to a loss of $0.31 from $0.32.
- Positive Sentiment: The analyst expects Alpha Cognition to reach approximately breakeven in Q4 2027, revising the forecast to $0.01 EPS from a $0.01 loss. This suggests improving longer-term operating trends, although profitability remains distant.
- Neutral Sentiment: HC Wainwright’s updated forecasts remain broadly aligned with the company’s loss-making profile: losses of $1.33 per share in FY2026 and $0.31 per share in FY2027, compared with the current-year consensus estimate of a $1.34 loss.
- Negative Sentiment: The firm reduced its FY2026 EPS estimate to a loss of $1.33 from $1.08 and cut Q3 2026 EPS expectations to a loss of $0.33 from $0.20. Q4 2026 was also lowered to a $0.25 loss from $0.20.
- Negative Sentiment: Q2 2027 and Q3 2027 estimates were reduced to losses of $0.13 and $0.07 per share, respectively. These revisions indicate that near-term expenses and cash-burn concerns may be greater than previously expected.
Alpha Cognition Trading Up 3.7%
Shares of ACOG stock traded up $0.32 during trading on Wednesday, reaching $8.89. 140,146 shares of the company’s stock traded hands, compared to its average volume of 128,612. The company has a market capitalization of $193.62 million, a P/E ratio of -8.08 and a beta of 2.31. The firm’s 50-day moving average is $7.91 and its 200 day moving average is $6.59. Alpha Cognition has a 1 year low of $4.50 and a 1 year high of $10.00.
Alpha Cognition (NASDAQ:ACOG – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.01). Alpha Cognition had a negative return on equity of 54.60% and a negative net margin of 153.61%.The business had revenue of $6.00 million during the quarter, compared to the consensus estimate of $4.38 million. As a group, sell-side analysts predict that Alpha Cognition will post -1.42 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Alpha Cognition
Hedge funds and other institutional investors have recently modified their holdings of the stock. Opaleye Management Inc. boosted its position in shares of Alpha Cognition by 1,698.5% in the fourth quarter. Opaleye Management Inc. now owns 2,070,784 shares of the company’s stock valued at $13,460,000 after acquiring an additional 1,955,642 shares during the period. AWM Investment Company Inc. bought a new position in shares of Alpha Cognition in the 2nd quarter worth $12,073,000. Ikarian Capital LLC increased its stake in Alpha Cognition by 11.6% in the fourth quarter. Ikarian Capital LLC now owns 1,056,259 shares of the company’s stock valued at $6,866,000 after acquiring an additional 110,000 shares during the last quarter. Cable Car Capital LP raised its holdings in shares of Alpha Cognition by 68.8% during the 2nd quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock valued at $8,108,000 after buying an additional 354,278 shares in the last quarter. Finally, Sphera Funds Management LTD. raised its stake in shares of Alpha Cognition by 67.6% during the fourth quarter. Sphera Funds Management LTD. now owns 567,616 shares of the company’s stock worth $3,690,000 after acquiring an additional 228,864 shares in the last quarter.
About Alpha Cognition
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Featured Stories
- Five stocks we like better than Alpha Cognition
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
